Tu et al.’s study also observed that mutations in SPP1 primarily occurred in cutaneous melanoma and endometrial cancer, with the ratio of alteration which ranged from 1.03 to 9.23% [33]. This evidence concerns the gene SPP1 and cutaneous melanoma.